Skip to main content

Table 3 ED visits as per EMR and chart review

From: Safety and adherence of early oral immunotherapy for peanut allergy in a primary care setting: a retrospective cross-sectional study

 

Total visits (n, %)

During escalation (n, %)

During maintenance (n, %)

Total ED visits

92

53 (57.6)

39 (42.4)

Admissions (included in ED visits)

2 (2.2)

1 (viral induced urticaria)

1 (asthma)

Infection

62 (67.4)

38 (71.7)

24 (61.5)

     Pneumonia

3 (3.3)

1 (1.9)

2 (5.1)

     Fever

9 (9.8)

6 (11.3)

3 (7.7)

     URTIa

25 (27.2)

17 (32.1)

8 (20.5)

     Urinarya

4 (4.3)

2 (3.8)

2 (5.1)

     GIa

6 (6.5)

3 (5.6)

3 (7.7)

     Skina

9 (9.8)

6 (11.3)

3 (7.7)

     Otitis Mediaa

6 (6.5)

2 (3.8)

4 (10.3)

Minor injurya

13 (14.1)

6 (11.3)

7 (17.9)

Wheezea

8 (8.7)

4 (7.5)

4 (10.3)

Miscellaneousa

5 (5.4)

3 (5.6)

2 (5.1)

Allergya

4 (4.3)

3 (5.6)

1 (2.6)

  1. Wheeze and urticaria cases had no temporal relationship to peanut OIT
  2. URTI: pharyngitis, tonsillitis, croup, sinusitis, URTI, unspecified respiratory infection; Urinary: UTI, swollen penis, oliguria; GI: gastroenteritis, norovirus; Skin: cellulitis, impetigo, red swollen ear, HFMD, viral exanthem, and viral induced urticarial; Otitis media: AOM, earache; Minor injury: minor head injury, superficial head injury, radial head subluxation, lower extremity injury, elbow injury, concussion, buckle fracture, cast check, head injury; Wheeze: asthma, wheeze, bronchiolitis; Miscellaneous: constipation, conjunctivitis, teething, lymphadenopathy, blood in stool; Allergy: hives and allergic reaction
  3. aED visit reasons